Dermatomyositis and polymyositis (myositis) trials in Georgia

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Enrolling by invitation
  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  Where

  Tbilisi

  Age

  18 years and over

  People

  240 worldwide

  Run by

  argenx

  See details and how to joinNCT05979441 · EU 2022-502851-79-00